Table 2.
Stage 0/ In-situ* |
No. | Stage I ** OR ‡ (CI) § |
No. | Stage II ** OR ‡ (CI) § |
No. | Stage III ** OR ‡ (CI) § |
|
---|---|---|---|---|---|---|---|
African- American (n=679) |
|||||||
Menopause^ | |||||||
Yes | 64 | 151 | 0.57 (0.35,0.92) | 119 | 0.51 (0.31, 0.83) | 20 | 0.41 (0.20,0.84) |
No | 34 | 141 | 1.00 | 124 | 1.00 | 26 | 1.00 |
Diabetes | |||||||
Yes | 29 | 73 | 0.79 (0.48, 1.32) | 59 | 0.76 (0.45, 1.29) | 9 | 0.58 (0.25, 1.35) |
No | 69 | 219 | 1.00 | 184 | 1.00 | 37 | 1.00 |
Diabetes Medication | |||||||
Yes | 26 | 62 | 0.75 (0.44, 1.27) | 49 | 0.70 (0.41, 1.21) | 7 | 0.50 (0.20, 1.25) |
No | 72 | 230 | 1.00 | 194 | 1.00 | 39 | 1.00 |
European- American (n=692) |
|||||||
Menopause | |||||||
Yes | 52 | 299 | 1.52 (0.88, 2.65) | 127 | 0.81 (0.46, 1.46) | 29 | 0. 88 (0.39, 1.97) |
No | 22 | 83 | 1.00 | 66 | 1.00 | 14 | 1.00 |
Diabetes | |||||||
Yes | 11 | 47 | 0.80 (0.40, 1.63) | 14 | 0.45 (0.19, 1.04) | 1 | 0.14 (0.02,1.04) |
No | 63 | 335 | 1.00 | 179 | 1.00 | 42 | 1.00 |
Diabetes Medication | |||||||
Yes | 7 | 40 | 1.12 (0.48, 2.61) | 11 | 0.58 (0.22, 1.55) | 1 | 0.23 (0.03, 1.92) |
No | 67 | 342 | 1.00 | 182 | 1.00 | 42 | 1.00 |
Menopause is estimated based on age (cut at age 55)
Controls- Stage 0- In situ
Stage I- Localized; Stage II- Regional; Stage III- Distant
Odds Ratio
95% Confidence Interval